Carolien Zeetsen

142 Crean, R.D., Crane, N.A., & Mason, B.J. (2011). An evidence based review of acute and long–term effects of cannabis use on executive cognitive functions. Journal of Addiction Medicine, 5 (1), 1–8. https://doi. org/10.1097/ADM.0b013e31820c23fa Crowe, S.F., Cammisuli, D.M., & Stranks, E.K. (2020). Widespread cognitive deficits in alcoholism persistent following prolonged abstinence: an updated meta–analysis of studies that used standardised neuropsychological assessment tools. Archives of Clinical Neuropsychology, 35 (1), 31–45. https:// doi.org/10.1093/arclin/acy106 Cumming, T.B., Lowe, D., Linden, T., Bernhardt, J., & AVERT Investigators Group. (2020). The AVERT MoCA data: scoring reliability in a large multicenter trial. Assessment, 27 (5), 976–981. https://doi. org/10.1177/1073191118771516 Cunha, P.J., Nicastri, S., Gomes, L.P., Moino, R.M., & Peluso, M.A. (2004). Neuropsychological impairments in crack cocaine–dependent inpatients: preliminary findings. Revista Brasileira de Psiquiatria, 26 (2), 103–106. https://doi.org/10.1590/s1516-44462004000200007 Czapla, M., Simon, J.J., Richter, B., Kluge, M., Friederich, H.C., Herpertz, S., Mann, K., Herpertz, S.C., & Loeber, S. (2015). The impact of cognitive impairment and impulsivity on relapse of alcohol–dependent patients: implications for psychotherapeutic treatment. Addiction Biology, 21 , 873–884. https://doi. org/10.1111/adb.12229 Davis, P.E., Liddiard, H., & McMillan, T.M. (2002). Neuropsychological deficits and opiate abuse. Drug and Alcohol Dependence, 67 (1), 105–108. https://doi.org/10.1016/S0376-8716 (02)00012-1 Delis, D.C., Kaplan, E., & Kramer, J.H. (2007). Trail Making Test: handleiding [Trail Making Test: manual]. Amsterdam, The Netherlands, Pearson. van den Berg, E., Kessels, R.P.C., de Haan, E.H.F., Kappelle, L.J., & Biessels, G.J. (2005). Mild impairments in cognition in patients with type 2 diabetes mellitus: the use of the concepts MCI and CIND. Journal of Neurology, Neurosurgery & Psychiatry, 76 (10), 1466–1467. https://doi.org/10.1136/jnnp.2005.062737 Dijkstra, B.A.G., Kamal, R., van Noorden, M.S., de Haan, H., Loonen, A.J.M., & de Jong, C.A.J. (2017). Detoxification with titration and tapering in Gamma–Hydroxybutyrate (GHB) dependent patients: the Dutch GHB monitor project. Drug and Alcohol Dependence, 170 , 164–173. https://doi.org/10.1016/j. drugalcdep.2016.11.014 Duits, A., & Kessels, R. (2014). Schatten van het premorbide functioneren [Estimating premorbid functioning]. InM. Hendriks, R. Kessels, M. Gorissen, B. Schmand, &A. Duits (Eds.), Neuropsychologische diagnostiek: de klinische praktijk (pp. 176–178). Amsterdam, The Netherlands, Boom. Eack, S.M., Hogarty, S.S., Bangalore, S.S., Keshavan, M.S., & Cornelius, J.R. (2016). Patterns of substance use during cognitive enhancement therapy: an 18–month randomized feasibility study. Journal of Dual Diagnosis, 12 (1), 74–82. https://doi.org/10.1080/15504263.2016.1145778 van der Elst, W., van Boxtel, M.P.J., van Breukelen, G.J.P., & Jolles, J. (2005). Rey’s verbal learning test: normative data for 1855 healthy participants aged 24–81 years and the influence of age, sex, education, and mode of presentation. Journal of the International Neuropsychological Society, 11 (3), 290–302. https://doi.org/10.1017/S1355617705050344